Drug intelligence / Profile preview

Ferachel Forte

Development stage
Unknown
Lead developer
Laborest
Modality
Small Molecules
Administration
Oral
01

Overview

Ferachel Forte is an oral multi-ingredient nutraceutical formulation primarily indicated for the management of iron deficiency anemia (IDA), particularly in specialized populations such as those with chronic kidney disease (CKD). Developed by Laborest (Uriach), the product features ferric sodium EDTA (sodium feredetate) as its core iron source. Ferric sodium EDTA is a stable chelate that prevents iron from reacting with dietary inhibitors in the gastrointestinal tract, thereby enhancing bioavailability and minimizing common side effects like gastric irritation. The formulation is further enriched with vitamin C to promote iron absorption, folic acid to support erythropoiesis, and essential trace elements including copper, zinc, and selenium, which act as enzymatic cofactors and antioxidants. Clinical evidence suggests that Ferachel Forte not only improves iron status and hemoglobin levels but also helps modulate systemic inflammation by reducing C-reactive protein and hepcidin levels, which are often elevated in CKD-related functional iron deficiency.

Brand names
Ferachel Forte

Beyond the preview

Go deeper on Ferachel Forte.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ferachel Forte.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call